<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Short-segment <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (SSBE) or long-segment <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (LSBE) is the consequence of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>), which is frequently associated with <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> is a significant risk factor for the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms, erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Morbidly <z:mp ids='MP_0001261'>obese</z:mp> patients who submitted to gastric bypass have an incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> as high as 50% to 100% and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> reaches up to 9% of patients </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In this prospective study, we evaluate the postoperative results after three different procedures--calibrated fundoplication + posterior gastropexy (CFPG), fundoplication + vagotomy + distal gastrectomy + Roux-en-Y gastrojejunostomy (FVDGRYGJ), and laparoscopic resectional Roux-en-Y gastric bypass (LRRYGBP)--among <z:mp ids='MP_0001261'>obese</z:mp> patients </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In patients with SSBE who submitted to CFPG, the persistence of reflux symptoms and endoscopic erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> was observed in 15% and 20.2% of them, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with LSBE were submitted to FVDGRYGJ or LRRYGBP which significantly improved their symptoms and erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>No modifications of LESP were observed in patients who submitted to LRRYGBP before or after the operation </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">Acid reflux</z:e> diminished after the three types of surgery were employed </plain></SENT>
<SENT sid="8" pm="."><plain>Patients who submitted to LRRYGBP presented a significant reduction of BMI from 41.5 ± 4.3 to 25.7 ± 1.3 kg/m(2) after 12 months </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Among patients with LSBE, FVDGRYGJ presents very good results in terms of improving <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, but the reduction of weight is limited </plain></SENT>
<SENT sid="10" pm="."><plain>LRRYGBP improves <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> disease and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with proven reduction in body weight and BMI, thus becoming the procedure of choice for <z:mp ids='MP_0001261'>obese</z:mp> patients </plain></SENT>
</text></document>